Owen N. Witte

This profile gathers the share dealings of Owen N. Witte across 2 companies, led by Allogene Therapeutics, Inc. and Kite Pharma, Inc. Over a trading history stretching from 14 March 2017 to 13 June 2023, the count stands at 23 filings.

In open-market terms, that means 1 purchase worth €233k on one side and 11 sales worth €3.4M on the other. Sales outweigh purchases by €3.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 2 option exercises.

The latest filing, published on 15 June 2023, reports a share grant in Allogene Therapeutics, Inc. The latest purchase dates back some time: it was published 2,945 days ago, on 17 October 2018. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.